In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
about
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsTargeting Antibiotic ResistanceTuberculosis therapy for 2016 and beyond.In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.Mycetoma medical therapy.Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of TuberculosisPipeline of Known Chemical Classes of Antibiotics.Early and extended early bactericidal activity of linezolid in pulmonary tuberculosisProdrugs for the treatment of neglected diseases.Recent advances in antituberculous drug development and novel drug targets.Current treatment for nocardia infections.Linezolid for Treating Tuberculosis: A Delicate Balancing Act.Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophagesLinezolid Resistance in Staphylococci.New agents approved for treatment of acute staphylococcal skin infectionsDevelopment of new antituberculous agents based on new drug targets and structure-activity relationship.In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control rangesIn vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia.Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.Systemic increased immune response to Nocardia brasiliensis co-exists with local immunosuppressive microenvironment.
P2860
Q26853612-41A60B24-5BB9-4A95-AF6A-3EAE0030AB79Q28078130-54D67F9E-8C85-499C-93C6-955387CD2198Q30248788-EDA89AA2-6ED8-49CE-8B9C-B45306D3E9EEQ35215417-D112A9C1-61E0-484C-979B-EB2CE1DB9227Q35351362-5394458F-4131-4910-8518-5E36A95AF853Q36439105-3005ACF9-0C72-46BC-94DA-FE5DCC18B704Q36683409-D02A408F-A0C4-400F-BCB8-3041F1176881Q36986669-E4B9AB3C-004C-4638-9ABC-BC23072194A5Q37157236-37B35658-9F49-47E0-A6E4-E3597514B5CCQ37754884-CFA2BB05-3A27-41B8-8EEE-D0E93A20B097Q38149157-7D8B9859-07A9-466D-8DA7-E81F3807F5DCQ38255352-7B4ABB99-7219-4237-A59E-B124A7BA22EDQ38352171-8930D075-4E1F-407A-A4C2-B054E600EB8CQ38749324-86CA1703-C5C9-4E04-8115-332E69A23EA0Q38974364-6FF139F5-8977-4550-8CFC-8C85012FE7FEQ39025172-C2A8F91D-8ADF-4C65-931C-7F8F86EC3A0CQ40138610-55576E95-7487-4013-865F-6EFEB7A9463DQ40283050-CFA0217D-4413-4E1D-9758-A539FDFB8190Q40334689-446EB206-BBA5-4F91-89F0-7E91FE9A7523Q41389487-AB63C930-D474-4145-A4A4-E5D1AAF144ABQ46304818-D5AF8B69-2704-4A9D-A531-C1C1F2319C38Q46765230-B7C8E50D-9E1B-4954-BCBE-8CF669E07C88Q48430704-FF31701A-5047-453F-BF9B-FE88CCAE69CA
P2860
In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vitro activities of DA-7157 ...... sis and Nocardia brasiliensis.
@en
type
label
In vitro activities of DA-7157 ...... sis and Nocardia brasiliensis.
@en
prefLabel
In vitro activities of DA-7157 ...... sis and Nocardia brasiliensis.
@en
P2093
P2860
P356
P1476
In vitro activities of DA-7157 ...... sis and Nocardia brasiliensis.
@en
P2093
Adrian Rendon
Eva Gonzalez
Jorge Ocampo-Candiani
Lucio Vera-Cabrera
Oliverio Welsh
Sung Hak Choi
Victor M Velazquez-Moreno
P2860
P304
P356
10.1128/AAC.00571-06
P407
P577
2006-09-01T00:00:00Z